Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 0 | 1.495.533 | 1.495.533 | 1 | ||
2013 | 0 | 3.909.300 | 3.174.750 | 2 | ||
2012 | 0 | 2.238.616 | 2.238.617 | 1 | ||
2011 | 0 | 2.999.996 | 1.961.324 | 2 |
Total number of partners: 762
Partner loyalty:
Frequent Partner: (> 2 projects): 196
Rare Partner: 566
Frequent / Rare Partner Ratio: 0.35
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-03-01 | "Inflammasome-induced IL-1 Secretion: Route, Mechanism, and Cell Fate" | FLAMMASEC | participant | 1.495.533 | 1 |
2013-02-01 | Regulation and Function of CARD9 / BCL10 / MALT1 Signalosomes in Innate Immunity and Inflammation | CBM-INNATE | participant | 2.440.200 | 1 |
2013-01-01 | Reverse engineering the vertebrate molecular machinery for magnetic biomineralisation | MAGNETOGENETICS | participant | 1.469.100 | 2 |
2012-06-01 | Multimodal Molecular Imaging | MUMI | participant | 2.238.616 | 1 |
2011-10-01 | The role of ROS/RNS during inflammation-associated and sporadic carcinogenesis | ROSCAN | participant | 1.500.000 | 2 |
2011-03-01 | Modeling congenital heart disease (CHD) in ISL1+ cardiovascular progenitors from patient-specific iPS cells | CHD-iPS | participant | 1.499.996 | 1 |